Casein Kinase 1δ Phosphorylates TDP-43 and Suppresses Its Function in Tau mRNA Processing.

BACKGROUND Neurofibrillary tangles aggregated from anomalous hyperphosphorylated tau is a hallmark of Alzheimer's disease (AD). Trans-active response DNA-binding protein of 43 kDa (TDP-43) enhances the instability and exon (E) 10 inclusion of tau mRNA. Cytoplasmic inclusion of hyperphosphorylated TDP-43 in the neurons constitutes the third most prevalent proteinopathy of AD. Casein kinase 1δ (CK1δ) is elevated in AD brain and phosphorylates TDP-43 in vitro. OBJECTIVE To determine the roles of CK1δ in phosphorylation, aggregation, and function of TDP-43 in the processing of tau mRNA. METHODS The interaction and colocalization of TDP-43 and CK1δ were analyzed by co-immunoprecipitation and immunofluorescence staining. TDP-43 phosphorylation by CK1δ was determined in vitro and in cultured cells. RIPA-insoluble TDP-43 aggregates obtained by ultracentrifugation were analyzed by immunoblots. The instability and E10 splicing of tau mRNA were studied by using a reporter of green fluorescence protein tailed with 3'-untranslational region of tau mRNA and a mini-tau gene and analyzed by real-time quantitative PCR and reverse transcriptional PCR. RESULTS We found that CK1δ interacted and co-localized with TDP-43. TDP-43 was phosphorylated by CK1δ at Ser379, Ser403/404, and Ser409/410 in vitro and in cultured cells, which was mutually enhanced. CK1δ overexpression promoted the aggregation of TDP-43 and suppressed its activity in enhancing the instability and E10 inclusion of tau mRNA. CONCLUSION CK1δ phosphorylates TDP-43, promotes its aggregation, and inhibits its activity in promoting the instability of tau mRNA and inclusion of tau E10. Elevated CK1δ in AD brain may contribute to TDP-43 and tau pathologies directly or indirectly.

[1]  J. Uslaner,et al.  Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology , 2021, Neurobiology of Disease.

[2]  Keith A. Johnson,et al.  Current directions in tau research: Highlights from Tau 2020 , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[3]  T. Raj,et al.  Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD , 2021, bioRxiv.

[4]  F. Chen,et al.  Phosphorylation of trans‐active response DNA‐binding protein‐of 43 kDa promotes its cytoplasmic aggregation and modulates its function in tau mRNA stability and exon 10 alternative splicing , 2021, Journal of neurochemistry.

[5]  K. Iqbal,et al.  Elevation of casein kinase 1ε associated with TDP‐43 and tau pathologies in Alzheimer's disease , 2020, Brain pathology.

[6]  C. Jack,et al.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report , 2019, Brain : a journal of neurology.

[7]  M. Goedert,et al.  Ordered Assembly of Tau Protein and Neurodegeneration. , 2019, Advances in experimental medicine and biology.

[8]  Fei Liu,et al.  Cyclic AMP-Dependent Protein Kinase Phosphorylates TDP-43 and Modulates Its Function in Tau mRNA Processing. , 2019, Journal of Alzheimer's disease : JAD.

[9]  B. Ghetti,et al.  Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration , 2018, Molecular Neurodegeneration.

[10]  Khadija Iqbal,et al.  Up-regulation of casein kinase 1ε is involved in tau pathogenesis in Alzheimer’s disease , 2017, Scientific Reports.

[11]  F. Chen,et al.  Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies , 2017, The Journal of Biological Chemistry.

[12]  K. Iqbal,et al.  Hyperphosphorylation determines both the spread and the morphology of tau pathology , 2016, Alzheimer's & Dementia.

[13]  Xinglong Wang,et al.  TDP-43 suppresses tau expression via promoting its mRNA instability , 2017, Nucleic acids research.

[14]  F. Kametani,et al.  Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains , 2016, Scientific Reports.

[15]  H. Akiyama,et al.  Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43* , 2016, The Journal of Biological Chemistry.

[16]  E. Masliah,et al.  A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick’s Disease and Fronto-Temporal Tauopathies , 2015, PloS one.

[17]  Thomas J. Montine,et al.  The Tau Tubulin Kinases TTBK1/2 Promote Accumulation of Pathological TDP-43 , 2014, PLoS genetics.

[18]  C. Jack,et al.  TDP-43 is a key player in the clinical features associated with Alzheimer’s disease , 2014, Acta Neuropathologica.

[19]  L. Petrucelli,et al.  Casein Kinase II Induced Polymerization of Soluble TDP-43 into Filaments Is Inhibited by Heat Shock Proteins , 2014, PloS one.

[20]  C. Jack,et al.  Staging TDP-43 pathology in Alzheimer’s disease , 2014, Acta Neuropathologica.

[21]  T. Bird,et al.  CDC7 inhibition blocks pathological TDP‐43 phosphorylation and neurodegeneration , 2013, Annals of neurology.

[22]  Cornelia M. Wilson,et al.  Tau protein kinases: Involvement in Alzheimer's disease , 2013, Ageing Research Reviews.

[23]  A. McKee,et al.  The spectrum of disease in chronic traumatic encephalopathy. , 2013, Brain : a journal of neurology.

[24]  H. Braak,et al.  Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? , 2011, Acta Neuropathologica.

[25]  D. Cleveland,et al.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.

[26]  H. Akiyama,et al.  Identification of casein kinase-1 phosphorylation sites on TDP-43. , 2009, Biochemical and biophysical research communications.

[27]  H. Akiyama,et al.  Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies , 2009, Acta Neuropathologica.

[28]  J. Trojanowski,et al.  Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies , 2009, Acta Neuropathologica.

[29]  I-Fan Wang,et al.  TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing* , 2008, Journal of Biological Chemistry.

[30]  T. Beach,et al.  Abnormal phosphorylation of Ser409/410 of TDP‐43 in FTLD‐U and ALS , 2008, FEBS letters.

[31]  M. Morita,et al.  Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis , 2008, Annals of neurology.

[32]  E. Buratti,et al.  Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[33]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[34]  Kit-Yi Leung,et al.  Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis* , 2007, Journal of Biological Chemistry.

[35]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[36]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[37]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[38]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[39]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[40]  Jianhua Zhou,et al.  A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10 , 2004, Journal of neurochemistry.

[41]  J. Kuret,et al.  Casein Kinase 1 Delta Phosphorylates Tau and Disrupts Its Binding to Microtubules* , 2004, Journal of Biological Chemistry.

[42]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[43]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[44]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[45]  J. Kuret,et al.  Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases , 2000, Neurobiology of Aging.

[46]  J. Kuret,et al.  Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain , 2000, Brain Research.

[47]  J. Kuret,et al.  A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease. , 1999, The American journal of pathology.

[48]  D Harrich,et al.  Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs , 1995, Journal of virology.

[49]  K. Kosik,et al.  Structure and novel exons of the human tau gene. , 1992, Biochemistry.

[50]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[51]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[52]  K. Kosik,et al.  Along the way to a neurofibrillary tangle: a look at the structure of tau. , 1989, Annals of medicine.

[53]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[54]  J. Ávila,et al.  Quantitation and characterization of tau factor in porcine tissues. , 1986, Biochimica et biophysica acta.